|
1
|
World Health Organization GLOBOCAN 2012, .
Estimated cancer incidence, mortality and prevalence worldwide in
2012. http://globocan.iarc.fr/Default.aspxAccessed.
October 10–2014.
|
|
2
|
Suh JH: Current readings: Pathology,
prognosis, and lung cancer. Semin Thorac Cardiovasc Surg. 25:14–21.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Detterbeck FC, Postmus PE and Tanoue LT:
The stage classification of lung cancer: Diagnosis and management
of lung cancer, 3rd ed: American College of Chest Physicians
evidence-based clinical practice guidelines. Chest. 143
(Suppl):e191S–e210S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
VanSchil PE, Sihoe AD and Travis WD:
Pathologic classification of adenocarcinoma of lung. J Surg Oncol.
108:320–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kris MG, Johnson BE, Kwiatkowski DJ, et
al: Identification of driver mutations in tumor specimens from
1,000 patients with lung adenocarcinoma: The NCI's lung cancer
mutation consortium (LCMC). J Clin Oncol. 29:CRA75062011.
|
|
6
|
Palmer JD, Zaorsky NG, Witek M and Lu B:
Molecular markers to predict clinical outcome and radiation induced
toxicity in lung cancer. J Thorac Dis. 6:387–398. 2014.PubMed/NCBI
|
|
7
|
Ulivi P, Zoli W, Capelli L, Chiadini E,
Calistri D and Amadori D: Target therapy in NSCLC patients:
Relevant clinical agents and tumour molecular characterisation. Mol
Clin Oncol. 1:575–581. 2013.PubMed/NCBI
|
|
8
|
Oxnard GR, Binder A and Jänne PA: New
targetable oncogenes in non-small-cell lung cancer. J Clin Oncol.
31:1097–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wooster R, Bignell G, Lancaster J, Swift
S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G:
Identification of the breast cancer susceptibility gene BRCA2.
Nature. 378:789–792. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miki Y, Swensen J, ShattuckEidens D,
Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM,
Ding W, et al: A strong candidate for the breast and ovarian cancer
susceptibility gene BRCA1. Science. 266:66–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fishel R, Lescoe MK, Rao MR, Copeland NG,
Jenkins NA, Garber J, Kane M and Kolodner R: The human mutator gene
homolog MSH2 and its association with hereditary nonpolyposis colon
cancer. Cell. 75:1027–1038. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bronner CE, Baker SM, Morrison PT, Warren
G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A,
et al: Mutation in the DNA mismatch repair gene homologue hMLH1 is
associated with hereditary non-polyposis colon cancer. Nature.
368:258–261. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Noesel J, van der Ven WH, van Os TA,
Kunst PW, Weegenaar J, Reinten RJ, Kancha RK, Duyster J and van
Noesel CJ: Activating germline R776H mutation in the epidermal
growth factor receptor associated with lung cancer with squamous
differentiation. J Clin Oncol. 31:e161–e164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohtsuka K, Ohnishi H, Kurai D, Matsushima
S, Morishita Y, Shinonaga M, Goto H and Watanabe T: Familial lung
adenocarcinoma caused by the EGFR V843I germ-line mutation. J Clin
Oncol. 29:e191–e192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamamoto H, Higasa K, Sakaguchi M, Shien
K, Soh J, Ichimura K, Furukawa M, Hashida S, Tsukuda K, Takigawa N,
et al: Novel germline mutation in the transmembrane domain of HER2
in familial lung adenocarcinomas. J Natl Cancer Inst.
106:djt3382014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M and DePristo MA: The genome analysis toolkit: A MapReduce
framework for analyzing next-generation DNA sequencing data. Genome
Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
DePristo MA, Banks E, Poplin R, Garimella
KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA,
Hanna M, et al: A framework for variation discovery and genotyping
using next-generation DNA sequencing data. Nat Genet. 43:491–498.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ettinger DS, Akerley W, Bepler G, et al:
NCCN Non-Small Cell Lung Cancer Panel Members: Non-small cell lung
cancer. J Natl Compr Canc Netw. 8:740–801. 2010.PubMed/NCBI
|
|
20
|
Forbes SA, Bindal N, Bamford S, et al:
COSMIC: mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer. Nucleic Acids Res. 39:945–950. 2011.
View Article : Google Scholar
|
|
21
|
Wong KA, Wilson J, Russo A, et al:
Intersectin (ITSN) family of scaffolds function as molecular hubs
in protein interaction networks. PLoS One. 7:e360232012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vinayagam A, Stelzl U, Foulle R, et al: A
directed protein interaction network for investigating
intracellular signal transduction. Sci Signal. 4:rs82011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DeWan AT, Egan KB, Hellenbrand K,
Sorrentino K, Pizzoferrato N, Walsh KM and Bracken MB: Whole-exome
sequencing of a pedigree segregating asthma. BMC Med Genet.
13:952012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu SH, Towler MC, Chen E, Chen CY, Song
W, Apodaca G and Brodsky FM: A novel clathrin homolog that
co-distributes with cytoskeletal components functions in the
trans-Golgi network. EMBO J. 20:272–284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sens-Abuázar C, Napolitano E, Ferreira E,
Osório CA, Krepischi AC, Ricca TI, Castro NP, da Cunha IW, Maciel
Mdo S, Rosenberg C and Brentani MM: Down-regulation of ANAPC13 and
CLTCL1: Early events in the progression of preinvasive ductal
carcinoma of the breast. Transl Oncol. 5:113–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
